Article Details

Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease | PNAS

Retrieved on: 2021-09-02 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease | PNAS. View article details on hiswai:

Excerpt

The compounds, including atazanavir, were initially identified by virtual screening, followed by fluorescence resonance energy transfer (FRET)-based biochemical ...

Article found on: www.pnas.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up